Chris Brinsmead CBE was an executive with Astrazeneca Plc, is chairman and non-executive director on many public and private boards. He has always wanted to make a difference, chairing Proveca makes a difference to children’s healthcare.
Chris wanted to be a tennis player when he grew up.
Simon is the CEO of Proveca, which he co-founded in 2010 following the trade sale of speciality pharma company Auralis which he co-founded in 2005. Prior to this, Simon held a series of senior management positions in large pharma and biotech.
Simon wanted to work in a sweet shop when he grew up, (inspired by Brenda, his friend’s Mum).
A qualified doctor with 25 years’ in the pharma industry covering global medical marketing and end to end product development. Having held Board positions in several pharma start-up companies Helen provides medical and clinical leadership to Proveca.
As a child Helen wanted to be the first woman to go to the moon.
Simon is an experienced pharmaceutical professional having held several senior roles including the head of Global Marketing capability for AstraZeneca
Simon has lived and worked across several European countries in sales and marketing, amassing first hand experience of several healthcare systems.
As a child, Simon wanted to join the Navy.
Andrew has worked with Proveca since its inception as Chief Financial Officer. Having qualified as an accountant in 2000. Andrew has a track record of working with several ambitious and successful healthcare and biotech companies across the UK.
As a child Andrew wanted to be a football journalist.
Christoph represents investor AlbionVC on the board of Proveca. He’s a partner at Albion, focusing on investments in healthcare. He initially practised as a radiologist, before spending time at Bain & Company, 3i PLC and General Electric. He holds a degree in medicine and an MBA from INSEAD.
As a child Christoph wanted to be a professional skateboarder but repeated injuries ultimately led him into medicine.
Gareth is an investor with Catapult Ventures. A scientist (Harvard Medical School, AstraZeneca), who moved into Business Development (Incyte, Cyprotex, Quotient) and became a CEO (Critical Pharmaceuticals). Growing up, Gareth wanted to be a musician.
Chris is a Vice President with Kreos Capital, an investor in Proveca. At Kreos, Chris invests in technology and healthcare companies across Europe and Israel. Previously a management consultant at the Parthenon Group and has held M&A roles at DB and EY. Holds an BCom from Otago University, is a CA and a CFA.
As a child Chris wanted to run a restaurant, this was more about enjoying eating than cooking.